Cell Impact AB (CI) - Total Assets
Based on the latest financial reports, Cell Impact AB (CI) holds total assets worth Skr216.69 Million SEK (≈ $23.32 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Cell Impact AB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Cell Impact AB - Total Assets Trend (2008–2024)
This chart illustrates how Cell Impact AB's total assets have evolved over time, based on quarterly financial data. Check Cell Impact AB tangible book value ratio to evaluate the tangible quality of the company's equity base.
Cell Impact AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Cell Impact AB's total assets of Skr216.69 Million consist of 28.0% current assets and 72.0% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 7.8% |
| Accounts Receivable | Skr8.74 Million | 3.4% |
| Inventory | Skr41.10 Million | 15.7% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr8.54 Million | 3.3% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how Cell Impact AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CI market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cell Impact AB's current assets represent 28.0% of total assets in 2024, a decrease from 100.0% in 2008.
- Cash Position: Cash and equivalents constituted 7.8% of total assets in 2024, down from 97.5% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 15.7% of total assets.
Cell Impact AB Competitors by Total Assets
Key competitors of Cell Impact AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dalian Demaishi Precision Technology Co.Ltd
SHE:301007
|
China | CN¥1.08 Billion |
|
Jiangyin Hengrun Heavy
SHG:603985
|
China | CN¥5.92 Billion |
|
Suzhou Chunqiu Electronic Technology Co Ltd Class A
SHG:603890
|
China | CN¥6.18 Billion |
|
RHI Magnesita NV
VI:RHIM
|
Austria | €4.42 Billion |
|
Pitti Engineering Limited
NSE:PITTIENG
|
India | Rs21.38 Billion |
|
Lee Chi Enterprises Co Ltd
TW:1517
|
Taiwan | NT$4.22 Billion |
|
Korvest Ltd
AU:KOV
|
Australia | AU$91.44 Million |
|
AML3D Ltd
AU:AL3
|
Australia | AU$37.55 Million |
Cell Impact AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.92 | 3.83 | 7.93 |
| Quick Ratio | 1.03 | 2.06 | 7.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr39.91 Million | Skr69.28 Million | Skr154.94 Million |
Cell Impact AB - Advanced Valuation Insights
This section examines the relationship between Cell Impact AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.49 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -31.6% |
| Total Assets | Skr261.25 Million |
| Market Capitalization | $3.03 Million USD |
Valuation Analysis
Below Book Valuation: The market values Cell Impact AB's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Cell Impact AB's assets decreased by 31.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Cell Impact AB (2008–2024)
The table below shows the annual total assets of Cell Impact AB from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr261.25 Million ≈ $28.11 Million |
-31.60% |
| 2023-12-31 | Skr381.93 Million ≈ $41.10 Million |
-4.88% |
| 2022-12-31 | Skr401.51 Million ≈ $43.21 Million |
+68.19% |
| 2021-12-31 | Skr238.72 Million ≈ $25.69 Million |
-1.71% |
| 2020-12-31 | Skr242.88 Million ≈ $26.14 Million |
+318.48% |
| 2019-12-31 | Skr58.04 Million ≈ $6.25 Million |
+52.41% |
| 2018-12-31 | Skr38.08 Million ≈ $4.10 Million |
+28.82% |
| 2017-12-31 | Skr29.56 Million ≈ $3.18 Million |
-43.67% |
| 2016-12-31 | Skr52.48 Million ≈ $5.65 Million |
+584.17% |
| 2015-12-31 | Skr7.67 Million ≈ $825.43K |
-32.14% |
| 2014-12-31 | Skr11.30 Million ≈ $1.22 Million |
-41.56% |
| 2013-12-31 | Skr19.34 Million ≈ $2.08 Million |
+262.26% |
| 2012-12-31 | Skr5.34 Million ≈ $574.56K |
-32.39% |
| 2011-12-31 | Skr7.90 Million ≈ $849.85K |
-51.57% |
| 2010-12-31 | Skr16.31 Million ≈ $1.75 Million |
+4187.53% |
| 2009-12-31 | Skr380.31K ≈ $40.93K |
-2.14% |
| 2008-12-31 | Skr388.63K ≈ $41.82K |
-- |
About Cell Impact AB
Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells and electrolyzers in the United States, Sweden, Other Europe, and Asia. The company offers production series of flow plates; design for manufacturing and other design services; tools and prototypes; local production; and leak testing, cleaning options, and advanced measurement instruments. The company was inc… Read more